Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2009
09/24/2009US20090239304 Bioactive peptide for cell adhesion
09/24/2009US20090239303 Ultrasonic Machining Fabrication of Guided Tissue Generation Surfaces and Tissue Scaffolds
09/24/2009US20090239302 Method for Constructing Functional Living Materials, Resulting Materials and Uses Thereof
09/24/2009US20090239301 Use of vinca alkaloids and salts thereof
09/24/2009US20090239300 Separating material and method for collecting cell or the like using the same
09/24/2009US20090239299 Autologous tissue harvesting and irrigation device
09/24/2009US20090239298 Methods of generating embryoid bodies using three dimensional scaffolds
09/24/2009US20090239297 Avian cell lines useful for the production of substrates of interest
09/24/2009US20090239296 for modifying glycans; treating or alleviating a symptom of an immune disorder, tissue injury or cancer
09/24/2009US20090239295 Dedifferentiated, Programmable Stem Cells of Monocytic Origin, and Their Production and Use
09/24/2009US20090239286 avian cell line infected with orthomyxovirus, paramyxovirus or orthopoxvirus; smallpox, influenza, measles; useful for the mass production of vaccines
09/24/2009US20090239282 Method of storing and/or transporting in vitro cell cultures
09/24/2009US20090239265 Virus like particles
09/24/2009US20090239262 Affinity Polypeptide for Purification of Recombinant Proteins
09/24/2009US20090239261 ASSEMBLY OF WILD-TYPE AND CHIMERIC INFLUENZA VIRUS-LIKE PARTICLES (VLPs)
09/24/2009US20090239259 Mammalian expression vectors and uses thereof
09/24/2009US20090239258 comprising the nucleotide sequence of SEQ ID NO:98 and/or the nucleotide sequence of SEQ ID NO:100; for diagnosing at least one IL-6 related condition in a cell, tissue, organ, animal or patient
09/24/2009US20090239254 Functional pigmented skin equivalent
09/24/2009US20090239235 Facs- and Reporter Protein-Based System for High Throughput Development of Therapeutic Proteins
09/24/2009US20090239217 Stem-like cells in bone sarcomas
09/24/2009US20090239216 Novel Tannase Gene And Protein Thereof
09/24/2009US20090239207 Method of assessing the viability of thawed cells
09/24/2009US20090238888 Radical polymerization method and products prepared thereby
09/24/2009US20090238874 Biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan
09/24/2009US20090238853 Hybrid Biomedical Device Fabricated From Biomaterials and Coated With a Natural Extra Cellular Matrix (ECM) Coating
09/24/2009US20090238843 Recombinant mva capable of expressing structural hcv antigens
09/24/2009US20090238837 High Affinity Siglec Ligands
09/24/2009US20090238832 Novel compositions and method for the treatment of psoriasis
09/24/2009US20090238831 Monoclonal antibodies and uses thereof
09/24/2009US20090238829 Stabilized single domain antibodies
09/24/2009US20090238825 Novel rabbit antibody humanization methods and humanized rabbit antibodies
09/24/2009US20090238823 Antigen binding proteins capable of binding thymic stromal lymphopoietin
09/24/2009US20090238822 Chimeric Hepatitis C Virus Antigens For Eliciting an Immune Response
09/24/2009US20090238821 Humanized antibodies that sequester amyloid beta peptide
09/24/2009US20090238817 Anti-cell proliferative compounds and methods of use
09/24/2009US20090238807 Cell line
09/24/2009US20090238805 Methods and compositions for increasing rna interference
09/24/2009US20090238803 Human cord blood derived unrestricted somatic stem cells (ussc)
09/24/2009US20090238802 Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem Cells
09/24/2009US20090238801 Amnion-derived stem cells and uses thereof
09/24/2009US20090238800 Isolation and therapeutic application of adult retinal stem cells collected from extra-retinal tissues
09/24/2009US20090238799 Conditionally-Immortalised Pancreatic Cells
09/24/2009US20090238798 Nucleotide Sequences Encoding Insecticidal Proteins
09/24/2009US20090238793 Toll like receptor (tlr) stimulation for ocular angiogenesis and macular degeneration
09/24/2009US20090238791 Il-15ralpha sushi domain as a selective and potent enhancer of il-15 action through il-15beta/gamma, and hyperagonist (il-15ralpha sushi - il-15) fusion proteins
09/24/2009US20090238789 Modified erythropoietin polypeptides and uses thereof
09/24/2009US20090238755 Use of antibodies or binding portions thereof, probes, ligands, or other biological agents which either recognize an extracellular domain of prostate specific membrane antigen or bind to and are internalized with prostate specific membrane antigen
09/24/2009CA2755933A1 Modulation of the immune response
09/24/2009CA2718961A1 Enhancing vessel lesion homing and repair potential of stem cells
09/24/2009CA2718904A1 Combined chemical and genetic approaches for generation of induced pluripotent stem cells
09/24/2009CA2718706A1 Partial peptide of lacritin
09/24/2009CA2712705A1 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
09/23/2009EP2103690A1 Method for modifying insect resistance of plants by utilizing rnai technique
09/23/2009EP2103689A1 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
09/23/2009EP2103688A2 Method for modifying plant morphology, biochemistry and physiology
09/23/2009EP2103687A1 Functional pigmented skin equivalent
09/23/2009EP2103686A1 Biotechnological process for isolation of hepatocytes from marine organisms
09/23/2009EP2103685A1 Vectors and methods for generating vector-free induced pluripotent stem (iPS) cells using site-specific recombination
09/23/2009EP2103684A1 Vascularisation enhanced graft constructs
09/23/2009EP2103683A1 Substrate for culture of cardiovascular tissue
09/23/2009EP2102331A1 Anti-tumor vaccine derived from normal chemically modified cells
09/23/2009EP2102330A1 Muscle derived cells for the treatment of gastro-esophageal pathologies and methods of making and using the same
09/23/2009EP2102329A1 Differentiated immortalised cell lines capable of producing albumin and blood coagulation factors, methods of preparing thereof from a leukaemia cell line and uses thereof
09/23/2009EP2102242A1 Antibodies against insulin-like growth factor i receptor and uses thereof
09/23/2009EP1706428B1 Anti-cancer antibodies with reduced complement fixation
09/23/2009EP1621207B1 Mixture of defibrotide and G-CSF, and its use for activating haematopoietic progenitors
09/23/2009EP1567539B1 Allele-specific rna interference
09/23/2009EP1542528B1 A method of treatment and prophylaxis
09/23/2009EP1482928B1 Mediators of hedgehog signaling pathways,compositions and uses related thereto
09/23/2009EP1423504B1 Compositions and methods for isolation, propagation, and differentiation of non-embryonic human stem cells and uses thereof
09/23/2009EP1360278B1 Lipase variants
09/23/2009EP1282684B1 Chondroitin synthase gene and methods of making and using same
09/23/2009EP1234880B9 Novel protein tab2
09/23/2009EP1086138B1 Monoclonal antibodies, cross-reactive antibodies and method for producing the same
09/23/2009EP1073734B1 Tumor associated nucleic acids and uses therefor
09/23/2009EP1068340B1 Method of suppressing gene expression in plants
09/23/2009EP1003781B1 Interleukin-18 binding proteins, their preparation and use
09/23/2009CN101541955A Hybrid suppressor tRNA for vertebrate cells
09/23/2009CN101541954A Use of a composition contaning human umbilical cord blood-derived mesenchymal stem cell for inducing differentiation and proliferation of neural precursor cells or neural stem cells to neural cells
09/23/2009CN101541953A Pancreatic and liver endoderm cells and tissue by differentiation of definitive endoderm cells obtained from human embryonic stems
09/23/2009CN101541952A Cell culture system, method for the production thereof and use in preclinical testing
09/23/2009CN101541951A Structure enclosing hematopoietic progenitor cells from ES cells and method for preparing blood cells using the same
09/23/2009CN101541950A Production of glycoproteins
09/23/2009CN101538585A Cell line capable of packaging recombinant retrovirus particles and preparation method thereof
09/23/2009CN101538584A Application of arachin Ara3 gene promoter to specific expression of driven foreign gene in transgenic plant seeds
09/23/2009CN101538576A Gene for generating related diterpene synthase together with tanshinone type compound as well as encoding product and application thereof
09/23/2009CN101538575A Scopolia acutangula hyoscyamine 6 Beta-hydroxylase gene, protein encoded thereby and application thereof
09/23/2009CN101538572A Recombinant lactic acid bacteria containing recombinant alpha-2b interferon and application thereof
09/23/2009CN101538555A Functional pigmented skin equivalent
09/23/2009CN101538553A Method for separating, purifying, culturing and proliferating totipotent stem cell from tissue of early aborted fetus of human being
09/23/2009CN101538552A Method for separating and cultivating rat hepatocytes
09/23/2009CN101538551A A device
09/23/2009CN101538327A Anthropogenic H5N1-resisting hemagglutinin protein broad-spectrum neutralising antibody and application thereof
09/23/2009CN101538326A Variable region sequence of hepatitis B virus monoclonal antibody, gene engineering antibody containing variable region and application thereof
09/23/2009CN101538322A Polypeptide with inhibiting transcriptional activation activity of transcription factor, encoding gene thereof and application
09/23/2009CN101538318A Signal peptide, coding genes thereof and application
09/23/2009CN101537173A Preparations stabilized over long time
09/23/2009CN101537016A Compound microcapsule preparation containing cartilage cells of epiphyseal plate, preparation method and application thereof
09/23/2009CN100543137C Novel forms of interfering RNA molecules
09/23/2009CN100543131C Process for animal cell non-serum clotting perfused culture